Home > Healthcare & Medical Devices > Home Sleep Apnea Testing Devices Market

Home Sleep Apnea Testing Devices Market Size By Test Type (Type 2, Type 3, Type 4), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI4439
  • Published Date: Aug 2022
  • Report Format: PDF

Industry Overview

Home Sleep Apnea Testing Devices Market size registered revenue over USD 810 million in 2021. The industry is projected to depict a CAGR of 16.8% through 2030, given the rising risks of chronic conditions such as heart diseases among patients with sleep disorders.
 

Home Sleep Apnea Testing Devices Market

Get more details on this report - Request Free Sample PDF
 

Sleep apnea tests can diagnose and calculate disease severity by monitoring the oxygen and breathing levels to measure the pauses in breathing across homecare settings. The rising number of patients diagnosed with sleep disorders and other associated co-morbidities will stimulate home sleep apnea testing devices market expansion. According to data from the American Sleep Association, nearly 50 million to 70 million U.S. adults have a sleep disorder, of which, 25 million are suffering from obstructive sleep apnea.
 

This expanding patient population is opting for devices with reliable and ergonomic designs that aid seamless at-home sleep apnea testing. For example, advanced, wearable sleep apnea testing devices with a user-friendly design, such as Lofta WatchPAT, have been made available for adults. The industry will therefore witness a strong growth trajectory, further influenced by the growing awareness about home sleep apnea tests among consumers.
 

Telemedicine has undergone technological advancements over recent years, ensuring seamless access to cost-effective treatments for sleep apnea and other diseases. As an alternative to traditional sleep studies conducted in labs, telemedicine options such as at-home sleep studies are becoming available to diagnose disease symptoms. It can also help patients select the right CPAP (continuous positive airway pressure) device and access ongoing monitoring. These innovations in telemedicine technologies will generate lucrative opportunities for market growth over the forecast period.
 

Strict regulatory norms to hamper the home sleep apnea testing devices market share

Government agencies have introduced stringent regulatory frameworks associated with the use of home sleep apnea devices. For example, the U.S. Food and Drug Administration has implemented exhaustive approval procedures and extremely rigid regulatory compliances for these devices. They are also classified as Class II devices due to their potential risks. Over the years, there have been product recalls, considering the health risks of exposure to chemicals and particulates, including asthma and respiratory tract irritation. These factors may create a hindrance to the development of home sleep test devices worldwide.
 

Type 3 sleep apnea testing devices with low technical complexity to gain traction

Global Home Sleep Apnea Testing Devices Market Share, By Test Type

Get more details on this report - Request Free Sample PDF
 

Based on test type, the market is divided into type 2, type 3, and type 4. Consumer preference for type 3 tests is rising, due to portability and ease of use. Their high sensitivity and specificity also aid in the accurate diagnosis of obstructive sleep apnea. Additionally, the introduction of novel type 3 tests with greater convenience and lower technical complexity has increased considerably. These factors will foster industry expansion from the type 3 segment, which held a 65% revenue share in 2021 and will be valued at over USD 2,240 million by 2030.
 

Emphasis on early disease diagnosis to spur the North America home sleep apnea testing devices market development

Global Home Sleep Apnea Testing Devices Market Share, By Region

Get more details on this report - Request Free Sample PDF
 

On the regional front, North America will emerge as a lucrative revenue pocket for the home sleep apnea testing devices market and record revenue of over USD 1,100 million by 2030, which can be credited to the robust presence of key product manufacturers. Furthermore, an increase in the prevalence of sleep disorders has been observed across the region. To limit the disease burden, patients are emphasizing early-stage diagnosis through the usage of home testing devices.
 

In countries including the U.S., symptoms of sleep apnea such as trouble concentrating, chronic headaches, and interrupted sleep are observed among several people. As per 2022 data from the Sleep Foundation, nearly 17% of women and 34% of men are diagnosed with obstructive sleep apnea in the U.S. As a result, home sleep apnea monitoring devices will emerge as a significant diagnostic tool, thereby stimulating regional industry dynamics.

 

Clinically validated therapy launches to strengthen home sleep apnea testing devices industry outlook

Compumedics Limited, Itamar Medical Inc., Natus Medical Inc., SOMNOmedics GmbH, Koninklijke Philips N.V., Resmed, and Nox Medical are some of the key home sleep apnea testing devices market players. These companies are mainly focusing on tapping into the latest technologies and expanding their product portfolio to strengthen their position in the market. For example, in September 2019, Philips announced the commercial launch of a prescription sleep position therapy device, NightBalance, for patients with positional obstructive sleep apnea. It also introduced a positional therapy that uses gentle vibrations to alter sleeping positions to help prevent apneas.
 

Impact of COVID-19 on the Home Sleep Apnea Testing Devices Market Outlook

The novel COVID-19 pandemic has posed unprecedented health concerns and asserted an adverse impact on home sleep apnea testing device manufacturers in the early months of 2020. In the initial stages of the pandemic, non-emergency treatments were delayed due to the imposition of lockdowns and other restrictions. To reduce disease transmission risks, people also preferred to avoid non-COVID-related treatment procedures. However, with the gradual ease of restrictions from the crisis in 2021, the adoption of home sleep testing equipment is likely to rise steadily, creating strong potential for global industry expansion over the forthcoming years.
 

The Home Sleep Apnea Testing Market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2030 for the following segments:

By Test Type

  • Type 2
  • Type 2
  • Type 3

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    South Africa
    • Saudi Arabia
    • UAE 
       
Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global market for home sleep apnea testing devices crossed USD 810 million in 2021 and is set to depict a CAGR of 16.8% through 2030.

The type 3 segment accounted for 65% of the home sleep testing devices industry share in 2021 and will be valued over USD 2,240 million by 2030, owing to its attributes such as portability, ease of use, and high sensitivity and specificity.

North America’s home sleep apnea testing devices industry will be valued at USD 1,100 million by 2030, due to the high prevalence of sleep disorders and awareness of early-stage diagnosis.

The competitive landscape of the home sleep apnea testing devices industry is inclusive of companies such as Koninklijke Philips N.V., Compumedics Limited, Itamar Medical Inc., Natus Medical Inc., SOMNOmedics GmbH, Resmed, and Nox Medical, among others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 14
  • Tables & Figures: 81
  • Countries covered: 18
  • Pages: 95

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount